Jan 24 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID PROVIDES POSITIVE REGULATORY UPDATE FOR D-PLEX₁₀₀
FOR
THE PREVENTION OF SURGICAL SITE INFECTIONS IN ABDOMINAL
COLORECTAL SURGERY
* POLYPID LTD - REGULATORY PATHWAY FOR A POTENTIAL NDA
SUBMISSION
CLARIFIED FOLLOWING RECENT INTERACTIONS WITH FDA
* POLYPID LTD - FDA ALSO RECOGNIZED THAT D-PLEX(100)'S
PROPOSED
INDICATION IS FOR PREVENTION OF INFECTION AND HAS POTENTIAL FOR
WIDE USE
* POLYPID LTD - IS NOW WORKING EXPEDITIOUSLY TO FINALIZE
DESIGN OF
REVISED SHIELD II TRIAL AND EXPECTS TO RESUME PATIENT
RECRUITMENT NEXT QUARTER
Source text for Eikon: ID:nGNX1w7q6q
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com;))